logo

Lannett Co Inc (LCI)



Trade LCI now with
  Date
  Headline
8/1/2019 4:48:38 PM Lannett Appoints John Kozlowski As CFO
7/8/2019 6:53:45 AM Lannett Enters Into Distribution Agreement For Levothyroxine
7/3/2019 6:58:07 AM Lannett Says Pleased With FDA's Decision That Regulatory Review Of NDA Can Continue
6/28/2019 6:59:10 AM Lannett Signs 3-year Agreement With Elite Pharmaceuticals To Be Exclusive U.S. Distributor Of Dantrolene Capsules
6/18/2019 6:54:35 AM Lannett Launches Aspirin And Extended-Release Dipyridamole Capsules
6/5/2019 6:54:20 AM Lannett Begins Human Clinical Trial Of Biosimilar Insulin Glargine Versus Us Lantus
5/29/2019 6:54:00 AM Lannett Commences Marketing Generic Concerta® (Press Release)
5/24/2019 6:52:00 AM Lannett Announces CFO Retirement (Press Release)
5/23/2019 6:54:01 AM Lannett Appoints Melissa Rewolinski To Board Of Directors
5/21/2019 6:53:12 AM Lannett Completes Purchase Of $30.5 Mln, Face Value, Of Its Term A Loans In Private Transaction
5/21/2019 6:52:00 AM Lannett Purchases Additional $30.5 Million Of Term A Loans (Press Release)
5/16/2019 6:52:00 AM Lannett Begins Marketing Generic Adderall® (Press Release)
5/6/2019 4:24:29 PM Lannett Q3 EPS Of $0.27 Vs. $0.33 Last Year
4/30/2019 7:40:24 AM Lannett To Launch Generic Concerta, AB-rated Methylphenidate Hydrochloride ER Tablets